| |
| |
|
| Insider
Information: |
Palleiko Benjamin L |
| Relationship: |
|
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
189,815 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,259,019 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
189,815 |
|
|
| Total
Value |
$2,259,019 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.7
|
| Percentage
Gain/Loss : |
0.0%
|
 160.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
SVP, Corporate Dev. & ... |
2007-09-14 |
2,500 |
2006-08-29 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
|
2024-02-20 |
187,315 |
2018-09-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO |
• – – |
2024-02-20 |
4 |
S |
$14.11 |
$321,846 |
D/D |
(22,802) |
187,315 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO |
• – – |
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,029 |
210,117 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO |
• – – |
2024-02-14 |
4 |
S |
$15.01 |
$613,205 |
D/D |
(40,855) |
159,088 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO |
• – – |
2024-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
199,943 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-11-20 |
4 |
S |
$8.23 |
$107,047 |
D/D |
(13,008) |
112,443 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,197 |
125,451 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-08-18 |
4 |
S |
$10.73 |
$140,192 |
D/D |
(13,067) |
95,254 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,195 |
108,321 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-05-18 |
4 |
S |
$10.14 |
$40,953 |
D/D |
(4,037) |
78,126 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,364 |
82,163 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-02-17 |
4 |
S |
$7.66 |
$37,948 |
D/D |
(4,954) |
72,799 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
President, CFO, CBO & Secy |
• – – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,363 |
77,753 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2022-11-18 |
4 |
S |
$5.44 |
$3,928 |
D/D |
(722) |
68,390 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2022-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,419 |
69,112 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2022-08-17 |
4 |
S |
$14.96 |
$10,847 |
D/D |
(725) |
66,693 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2022-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,418 |
67,418 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2021-02-23 |
4 |
AS |
$31.77 |
$995,562 |
D/D |
(29,642) |
65,000 |
0 |
% |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2021-02-23 |
4 |
OE |
$6.74 |
$199,787 |
D/D |
29,642 |
94,642 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO, CBO & Secretary |
• – – |
2021-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
65,000 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CBO, CFO and Secretary |
• – – |
2019-04-22 |
4 |
OE |
$8.39 |
$16,780 |
D/D |
2,000 |
34,500 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CBO, CFO and Secretary |
• – – |
2019-04-22 |
4 |
S |
$25.80 |
$51,603 |
D/D |
(2,000) |
32,500 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CBO, CFO and Secretary |
• – – |
2019-04-18 |
4 |
S |
$25.51 |
$27,373 |
D/D |
(1,073) |
32,500 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CBO, CFO and Secretary |
• – – |
2019-04-18 |
4 |
OE |
$6.74 |
$7,232 |
D/D |
1,073 |
33,573 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
CFO and Secretary |
• – – |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
32,500 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
SVP, Corporate Dev. & CFO |
• – – |
2007-09-14 |
4 |
B |
$10.87 |
$16,305 |
D/D |
1,500 |
2,500 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
